Cited by 724Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysHeat shock proteins research

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

Open access

Honda, Reiko, Yasuda, Hideyo·1999·The EMBO Journal

Open this paper in CoChat — free account Open PDF

Abstract

We have demonstrated previously that the oncoprotein Mdm2 has a ubiquitin ligase activity for the tumor suppressor p53 protein. In the present study, we characterize this ubiquitin ligase activity of Mdm2. We first demonstrate the ubiquitination of several p53 point mutants and deletion mutants by Mdm2. The point mutants, which cannot bind to Mdm2, are not ubiquitinated by Mdm2. The ubiquitination of the C-terminal deletion mutants, which contain so-called Mdm2-binding sites, is markedly decreased, compared with that of wild-type p53. The binding of Mdm2 to p53 is essential for ubiquitination, but p53's tertiary structure and/or C-terminal region may also be important for this reaction. DNA-dependent protein kinase is known to phosphorylate p53 on Mdm2-binding sites, where DNA damage induces phosphorylation, and p53 phosphorylated by this kinase is not a good substrate for Mdm2. This suggests that DNA damage-induced phosphorylation stabilizes p53 by inhibiting its ubiquitination by Mdm2. We further investigated whether the tumor suppressor p19(ARF) affects the ubiquitin ligase activity of Mdm2 for p53. The activity of p19(ARF)-bound Mdm2 was found to be lower than that of free Mdm2, suggesting that p19(ARF) promotes the stabilization of p53 by inactivating Mdm2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/emboj/18.1.22

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“When Mdm2 cDNA is transfected into human cells, p53 degradation is accelerated (Haupt et al., 1997; Kubbutat et al., 1997).”
Background
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042

Show all 43 references

Sorted by citations

Items 501–600 of 721

Inauhzin(c) Inactivates c-Myc Independently of p53
Jung, J. H., Liao, J., Zhang, Q., Zeng, S. X., Nguyen, D., Hao, Q., Zhou, X. Y., Cao, B., Kim, S., & Lu, H. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1002698 · Cited by 17
The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization
Zeng, S. X., Jin, Y., Kuninger, D., Rotwein, P. S., & Lu, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209030200 · Cited by 17
A novel putative collaborator of p19ARF
Wadhwa, R. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00180-8 · Cited by 17
A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF
Hashemi, J., Lindström, M. S., Asker, C., Platz, A., Hansson, J., & Wiman, K. G. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00027-7 · Cited by 16
ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2
Chang, D. L. F., Qiu, W., Ying, H., Zhang, T., Chen, C. Y., & Xiao, Z.-X. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210254 · Cited by 16
Tumor-specific induction of apoptosis by a p53-reactivating compound
Hedström, E., Issaeva, N., Enge, M., & Selivanova, G. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.009 · Cited by 15
Responses of genes involved in cell cycle control to diverse DNA damaging chemicals in human lung adenocarcinoma A549 cells.
Zhu, H., Smith, C. C., Ansah, C., & Gooderham, N. J. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-28 · Cited by 15
Clinical Implications of CSN6 Protein Expression and Correlation with Mutant-type P53 Protein in Breast Cancer
Wang, W., Tang, M., Zhang, L., Xu, X., Qi, X., Yang, Y., Jin, F., & Chen, B. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt148 · Cited by 15
Towards a Better Understanding of the Molecular Mechanisms Involved in Sunlight‐Induced Melanoma
Williams, M., & Ouhtit, A. (2005) · BioMed Research International · doi:10.1155/jbb.2005.57 · Cited by 16
A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin, J., Jin, X., Page, C., Sondak, V. K., Jiang, G., & Reynolds, R. K. (2000) · PubMed · Cited by 15
Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
Kowalczyk, D., Nakasone, M. A., Smith, B. O., & Huang, D. T. C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201472 · Cited by 15
Metal-Based Anticancer Complexes and p53: How Much Do We Know?
Alfadul, S. M., Matnurov, E. M., Varakutin, A. E., & Babak, M. V. (2023) · Cancers · doi:10.3390/cancers15102834 · Cited by 15
Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor
Minges, J. T., Grossman, G., Zhang, P., Kafri, T., & Wilson, E. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.663641 · Cited by 15
HER-2/Neu signaling and therapeutic approaches in breast cancer
Zhou, B. P., Li, Y., & Hung, M. (2002) · Breast Disease · doi:10.3233/bd-2002-15103 · Cited by 14
MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia
Clavero, A. L., Boqvist, P. L., Ingelshed, K., Bosdotter, C., Sedimbi, S. K., Jiang, L., Wermeling, F., Vojtěšek, B., Lane, D. P., & Kannan, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-31484-0 · Cited by 13
Genetics, cellular biology and tumor microenvironment of melanoma
Ch’ng, S. (2009) · Frontiers in bioscience · doi:10.2741/3286 · Cited by 14
Novel Aspects in Acute Lymphoblastic Leukemia
Faderl, S. H. (2011) · InTech eBooks · doi:10.5772/1050 · Cited by 13
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis
Dreidax, D., Gogolin, S., Schroeder, C., Muth, D., Brueckner, L. M., Hess, E. M., Zapatka, M., Theißen, J., Fischer, M., Ehemann, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt020 · Cited by 13
Defect in the p53-Mdm2 Autoregulatory Loop Resulting from Inactivation of TAF II 250 in Cell Cycle Mutant tsBN462 Cells
Wasylyk, C., & Wasylyk, B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5554-5570.2000 · Cited by 13
A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein
Veldhoen, N., Metcalfe, S. M., & Milner, J. (1999) · Oncogene · doi:10.1038/sj.onc.1203182 · Cited by 13
Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1
Huschtscha, L. I., Moore, J. D., Noble, J. R., Campbell, H. G., Royds, J. A., Braithwaite, A. W., & Reddel, R. R. (2009) · Journal of Cell Science · doi:10.1242/jcs.044107 · Cited by 12
Proteomics analysis in Caenorhabditis elegans to elucidate the response induced by tyrosol, an olive phenol that stimulates longevity and stress resistance
Cañuelo, A., & Peragón, J. (2013) · PROTEOMICS · doi:10.1002/pmic.201200579 · Cited by 12
Regulation of apoptosis in the female reproductive system
Vaskivuo, T. E. (2002) · Cited by 12
Identification of a Novel Rb-regulated Gene Associated with the Cell Cycle
Sung, Y. H., Kim, H. J., & Lee, H. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07357-0 · Cited by 12
Apoptosis as a therapeutic paradigm in inflammatory bowel diseases.
Verstege, M. I., Velde, A. A. T., & Hommes, D. W. (2006) · PubMed · Cited by 12
Genetic Instability, Oncogenes, and the p53 PathwayPreprint
Wahl, G. M., & Vafa, O. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.511 · Cited by 12
p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner
Li, Y., He, L., Bruce, A., Parihar, K., Ingram, A. J., Liu, L., & Tang, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.011 · Cited by 11
The shady side of sunlight current understanding of the mechanisms underlying UV-induction of skin cancers
Trappey, A. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s42 · Cited by 10
E2F1-CDK1 pathway activation in kanamycin-induced spiral ganglion cell apoptosis and the protective effect of CR8
Liu, Y., Wang, G., Peng, Z., Guo, J., Wu, Q. V., Xie, J., & Gong, S. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.034 · Cited by 10
Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts
Ueda, Y., Koya, T., Yoneda‐Kato, N., & Kato, J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.032 · Cited by 10
Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance
Guo-chang, F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00524-3 · Cited by 10
Suppression of E1A-Mediated Transformation by the p50E4F Transcription Factor
Fernandes, E. R., & Rooney, R. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4739 · Cited by 10
Transcription factor E4F1 as a regulator of cell life and disease progression
Sun, S., Zhong, B., Zeng, X. Y., Li, J., & Chen, Q. (2023) · Science Advances · doi:10.1126/sciadv.adh1991 · Cited by 9
Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks
Ghasemi, N., & Azizi, H. (2024) · Gene · doi:10.1016/j.gene.2024.148447 · Cited by 9
Transforming Growth Factor β1 (TGF-β1) Suppresses Growth of B-cell Lymphoma Cells by p14ARF-dependent Regulation of Mutant p53
Chen, G., Ghosh, P., O’Farrell, T. J., Munk, R. B., Rezanka, L. J., Sasaki, C. Y., & Longo, D. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351411 · Cited by 11
Bifurcation in Cell Cycle Dynamics Regulated by p53
Alam, M. J., Kumar, S., Singh, V., & Singh, R. K. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129620 · Cited by 9
Mutational analysis reveals a dual role of Mdm2 acidic domain in the regulation of p53 stability
Doleželová, P., Cetkovská, K., Vousden, K. H., & Uldrijan, S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.034 · Cited by 9
Molecular pathology and potential therapeutic targets in soft-tissue sarcoma
Todd, R., & Lunec, J. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.6.939 · Cited by 9
A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene
Bartl, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg207 · Cited by 8
Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA
Lunec, J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1267 · Cited by 8
The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF-β Resistance
Kannemeier, C., Liao, R., & Sun, P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0844 · Cited by 8
Polymorphisms in the p53 pathway genes and micronucleus occurrence in Chinese vinyl chloride-exposed workers
Li, Y., Feng, N.-N., Zhang, G.-H., Wang, Q., Hao, Y.-H., Ya-Nanzhang, Long, C., Li, Y., Brandt‐Rauf, P. W., & Xia, Z.-L. (2013) · International Journal of Occupational Medicine and Environmental Health · doi:10.2478/s13382-013-0155-6 · Cited by 8
Molecular and Genetic Events in Neoplastic Transformation
Erson-Bensan, A. E., & Petty, E. M. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0004 · Cited by 8
PKCα is involved in phorbol ester TPA-mediated stabilization of p14ARF
Inoue, R., & Shiraishi, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.117 · Cited by 9
The INK4A/Arf Network — Cell Cycle Checkpoint or Emergency Brake?
del Arroyo, A. G., & Peters, G. G. (2005) · Advances in experimental medicine and biology · doi:10.1007/1-4020-3764-3_8 · Cited by 8
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 9
Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2 pathway
Zhang, P., Kratz, A.-S., Salama, M., Elabd, S., Heinrich, T., Wittbrodt, J., Blattner, C., & Davidson, G. R. (2015) · BMC Biotechnology · doi:10.1186/s12896-015-0208-y · Cited by 7
Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1)
Chipps, E., Protzman, A. D., Muhi, M. Z., Ando, S., Calvet, J. P., & Islam, M. R. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25238 · Cited by 7
Role of Zataria multiflora Boiss. Essential oil in Regulation of MDM2 and ATM Genes Expression in Rat
Gohar, A. V., Mohammadi, A., & Sharififar, F. (2010) · Asian Journal of Plant Sciences · doi:10.3923/ajps.2010.134.139 · Cited by 7
The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop
Almog, N. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.779 · Cited by 7
Control of the Cell Cycle
Malumbres, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00004-9 · Cited by 10
Mechanisms of Asbestos-Induced Carcinogenesis
Toyokuni, S., Jiang, L., Hu, Q., Nagai, H., Okazaki, Y., Akatsuka, S., & Yamashita, Y. (2011) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.66.562 · Cited by 8
Peptidomimetics II
Lubell, W. D. (2016) · Topics in heterocyclic chemistry · doi:10.1007/978-3-319-49124-0 · Cited by 7
Anomalies géniques dans les carcinomes épidermoïdes des voies aérodigestives supérieures : analyse de la littérature internationale
Raybaud, H., Odin, G., Fafet, A., Santini, J., & Monteil, R. A. (2003) · Pathologie Biologie · doi:10.1016/s0369-8114(03)00016-6 · Cited by 7
Transformation of primary murine peritoneal mast cells by constitutive KIT activation is accompanied by loss of Cdkn2a/Arf expression
Capellmann, S., Sonntag, R., Schüler, H. M., Meurer, S. K., Gan, L., Kauffmann, M., Horn, K., Königs‐Werner, H., Weiskirchen, R., Liedtke, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1154416 · Cited by 7
Adenovirus Ad-p53AIP1-mediated gene therapy and its regulation of p53-MDM2 interactions
Jiang, Y., Chen, H., Jia, H., Xu, Y., LIU, G., Wang, Y., Yang, X., & Lu, Y. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm_00000057 · Cited by 6
p53 N-terminal binding and stabilisation by PIAS3 inhibits MDM2-induced p53 ubiquitination and regulates cell growth
Zhao, Z., Wu, L., Shi, H., & Wu, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1993 · Cited by 6
Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein
Dart, D. A., Mansoor, M. S., Loadman, P. M., & Picksley, S. M. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.12.1825 · Cited by 6
Engaging Ly‐6A/Sca‐1 triggers lipid raft‐dependent and ‐independent responses in CD4+ T‐cell lines
Lang, M. A., Jenkins, S. A., Balzano, P., Owoyele, A., Patel, A., & Bamezai, A. K. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.182 · Cited by 6
Zellzyklus und Apoptose
Daniel, P. T. (2003) · Springer eBooks · doi:10.1007/978-3-642-59343-7_5 · Cited by 5
Identification of the gene immediately downstream of the murine INK4a/ARF locus
Pantoja, C., Palmero, I., & Serrano, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00104-8 · Cited by 6
Extra-Ribosome Functions of Ribosomal Proteins
Franklin, D. A., & Zhang, Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30038-4 · Cited by 7
Molecular Genetics and Cancer Biology
Gonzalgo, M. L., & Meeker, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00018-9 · Cited by 5
Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis
Bouzid, A., Ani, M. A., de la Fuente, D., Shareef, Z. A., Quadri, A., Hamoudi, R., & Al-Rawi, N. H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1128753 · Cited by 5
Aberrant Anaplastic Lymphoma Kinase Activity Induces a p53 and Rb-Dependent Senescence-Like Arrest in the Absence of Detectable p53 Stabilization
McDuff, F. K. E., & Turner, S. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017854 · Cited by 6
Nuclear tumor suppressors in space and time
Barbie, D. A., Conlan, L. A., & Kennedy, B. K. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.05.005 · Cited by 5
A cell-based screening method for specifically detecting kinase activity
Suda, M., Ishii, T., Sootome, H., King, A. J., Shibahara, M., Noro, N., Yamashita, K., & Noumi, T. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1685-1 · Cited by 5
p53 Tumor Suppressor Protein
Ashcroft, M. A., & Vousden, K. H. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_7 · Cited by 5
Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators
Schlott, T., Scharf, J., Gorzel, C., Middel, P., & Spring, H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600238 · Cited by 5
Transition and identification of pathological states in p53 dynamics for therapeutic intervention
Jangid, A., Malik, M. Z., Ramaswamy, R., & Singh, R. K. B. (2021) · Scientific Reports · doi:10.1038/s41598-021-82054-1 · Cited by 5
Splicing DNA Damage Adaptations for the Management of Cancer Cells
Singh, A. K., Yadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232258528231018113410 · Cited by 4
Identification and functional characterization of an Rbx1 in an invertebrate Haliotis diversicolor supertexta
Wu, L., Wu, X., & Wang, L. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.08.008 · Cited by 4
Multi-scale modeling of cell survival and death mediated by the p53 network: a systems pharmacology framework
Wang, Y., Guo, Z., Chen, X., Zhang, W., Lü, A., & Wang, Y. (2015) · Molecular BioSystems · doi:10.1039/c5mb00304k · Cited by 4
Inhibiteurs des kinases dépendantes des cyclines et sénescence réplicative
Gerland, L., Ffrench, M., & Magaud, J. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00249-8 · Cited by 4
SUMO-specific protease SENP3 enhances MDM2-mediated ubiquitination of PARIS/ZNF746 in HeLa cells
Nishida, T. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.05.065 · Cited by 4
Control of the Cell Cycle
Malumbres, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00004-7 · Cited by 5
Ubiquitin Family Members in the Regulation of the Tumor Suppressor p53
Xirodimas, D. P., & Scheffner, M. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_10 · Cited by 5
Hematopoietic malignancies associated with increased Stat5 and Bcl-xL expressions in Ink4a/Arf-deficient mice
Sung, Y. H., Park, J., Choi, B., Kim, J., Cheong, C., Choi, Y. S., Yang, E. Y., Lee, M. J., Han, J., Park, S. C., et al. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.007 · Cited by 4
The N-terminal domain of MDM2 resembles calmodulin and its relatives 1 1Edited by J. M. Thornton
Milner‐White, E. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3125 · Cited by 4
Pharmacogenomics of the p53 tumor suppressor and its role in cancer chemoresistance
Liu, S., Bishop, W. R., Dasmahapatra, B., & Wang, Y. (2004) · Drug Development Research · doi:10.1002/ddr.10362 · Cited by 4
Elucidating the Role of CNOT2 in Regulating Cancer Cell Growth via the Modulation of p53 and c-Myc Expression
Lee, J., Kim, J., Lee, Y. J., Oh, J. H., Han, Y. J., & Jung, J. H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080615 · Cited by 3
Alterations in TP53 gene – Implications in Tumorigenesis Process and Prognosis in Central Nervous System Cancer
Pessôa, I. A., da Silva, F. P. E., Anselmo, N. P., & de Oliveira, E. H. C. (2014) · InTech eBooks · doi:10.5772/58334 · Cited by 5
Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia
Cividin, M., Ayrault, O., Sorel, N., Seité, P., Brizard, F., Blanchet, O., Mahon, F., Guilhot, F., Larsen, C. J., Chomel, J., et al. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.02.002 · Cited by 3
Interaction of p14ARF with Brca1 in cancer cell lines and primary breast cancer
He, L., Fan, C., Ning, X., Feng, X., Liu, Y., Chen, B., & Tang, D. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.07.018 · Cited by 3
Chronic HIV Type 1 Infection Down-regulates Expression of DAP Kinase and p19 ARF -p53 Checkpoint and Is Associated with Resistance to CD95-Mediated Apoptosis in HUT78 T Cells
Kim, C. H., Chiplunkar, S., & Gupta, S. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204773004905 · Cited by 3
The p14ARF Alternate Reading Frame Protein Enhances DNA Binding of Topoisomerase I by Interacting with the Serine 506-Phosphorylated Core Domain
Bandyopadhyay, K., Li, P., & Gjerset, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058835 · Cited by 3
A Robust, Target-Driven, Cell-Based Assay for Checkpoint Kinase 1 Inhibitors
Ishii, T., Sootome, H., King, A. J., Suda, M., Noro, N., Yamashita, K., & Noumi, T. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107303323 · Cited by 3
Independent regulation of P53 stabilisation and activation after Rb deletion in primary epithelial cells
Treanor (2010) · International Journal of Oncology · doi:10.3892/ijo_00000650 · Cited by 3
p19Arf limits primary vitreous cell proliferation driven by PDGF-B
Iqbal, N. S., Devitt, C. C., Sung, C. Y., & Skapek, S. X. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.01.004 · Cited by 3
Cancer RNome: Evolution and Sustenance
Arora, M., & Kaul, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1568-8_3 · Cited by 3
Activation of p53 in anoxic freshwater crayfish, Faxonius virilis
Gupta, A., Breedon, S. A., & Storey, K. B. (2022) · Journal of Experimental Biology · doi:10.1242/jeb.244145 · Cited by 3
Targeting the MDM2–p53 Protein–Protein Interaction
Hardcastle, I. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00013-9 · Cited by 3
RING Fingers and Relatives: Determinators of Protein Fate
Lorick, K. L., Tsai, Y. C., Yang, Y., & Weissman, A. M. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch4 · Cited by 3
Characterization of the E3 Ubiquitin Ligase Pirh2
Tai, E. (2010) · TSpace (University of Toronto) · Cited by 3
Functional Rescue of Mutant p53 as a Strategy to Combat Cancer
Selivanova, G., & Wiman, K. G. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50021-7 · Cited by 3
Reduced murine double minute 2 and 4 protein, but not messenger RNA , expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia
Salomao, N., Maslah, N., Giulianelli, A., Drevon, L., Aguinaga, L., Gu, X., Cassinat, B., Giraudier, S., Fenaux, P., & Fåhræus, R. (2022) · British Journal of Haematology · doi:10.1111/bjh.18608 · Cited by 2
The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinoma
Santos, L. L., Pereira, M. K., Costa, C., Amaro, T., Lameiras, C., Pereira, S., Lopes, P. S., Alonso, B. C., Koch, A., & Lopes, C. S. (2002) · Revista de Oncología · doi:10.1007/bf02832107 · Cited by 2
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 2
ATP-Utilizing Enzymes, Purinergic Receptor Modulation, Cupredoxins and Mammalian Cell Death
Yamada, T., & Chakrabarty, A. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9084-6_2 · Cited by 2
Signaling Pathways that Regulate C. elegans Life Span
Ruvkun, G., Samuelson, A. V., Carr, C. E., Curran, S. P., & Shore, D. E. (2009) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-642-04302-4_6 · Cited by 2

Authors: Honda, R., & Yasuda, H.
Affiliations: Tokyo University of Pharmacy and Life Sciences (JP)
Corresponding author: Yasuda, Hideyo
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1999-01-04
Volume: 18
Issue: 1
Pages: 22-27
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1093/emboj/18.1.22
PMC: PMC1171098
OpenAlex: W2028210102
Cited by: 724
References: 43
Citations by year: 2026: 1 · 2025: 3 · 2024: 3 · 2023: 12 · 2022: 12 · 2021: 3 · 2020: 10 · 2019: 4 · 2018: 11 · 2017: 5 · 2016: 14 · 2015: 19 · 2014: 20 · 2013: 24 · 2012: 20
FWCI: 33.88
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: European Molecular Biology Organization
Institute of Genetics
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p19ARF, MDM2, p53, ubiquitin ligase activity, p53 ubiquitination, p53 stabilization, DNA-dependent protein kinase, p53 phosphorylation, DNA damage response, tumor suppressor proteins, protein-protein interaction
MeSH terms: Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, HeLa Cells, Humans, Ligases, Mutation, Nuclear Proteins, Phosphorylation, Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Ubiquitins, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Spodoptera, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks